Related Experiment Video
Updated: Nov 15, 2025

06:30
Endovascular Perforation Model for Subarachnoid Hemorrhage Combined with Magnetic Resonance Imaging MRI
Published on: December 16, 2021
4.1K
Scoring Model to Predict Functional Outcome in Poor-Grade Aneurysmal Subarachnoid Hemorrhage
Jie Shen1, Jianbo Yu1, Sicong Huang1
1Department of Neurosurgery, College of Medicine, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Frontiers in Neurology
|March 8, 2021
Summary
A new scoring model accurately predicts outcomes for patients with poor-grade aneurysmal subarachnoid hemorrhage (aSAH). This tool aids in clinical decision-making for better patient management and treatment strategies.
Area of Science:
- Neurosurgery
- Neurology
- Critical Care Medicine
Background:
- Poor-grade aneurysmal subarachnoid hemorrhage (aSAH), defined by World Federation of Neurosurgical Societies (WFNS) grades IV-V, is associated with high disability and mortality rates.
- Accurate prognostication is crucial for managing these critically ill patients.
Purpose of the Study:
- To develop and validate a novel scoring model for precise outcome prediction in patients with poor-grade aSAH.
- To identify key predictors of poor prognosis in this patient population.
Main Methods:
- A scoring model was developed using multivariate logistic regression analysis on data from 147 poor-grade aSAH patients.
- Risk variables included modified Fisher grade, age, treatment strategy, WFNS grade, delayed cerebral ischemia, hydrocephalus, and cerebral herniation.
- The model was validated using a separate cohort of 68 patients.
Main Results:
- The developed scoring system identified significant predictors of poor prognosis (modified Rankin Scale [mRS] ≥3), including modified Fisher grade >2, age ≥65, conservative treatment, WFNS grade V, delayed cerebral ischemia, shunt-dependent hydrocephalus, and cerebral herniation.
- The model categorized patients into low (0-1 points), intermediate (2-3 points), and high (4-9 points) risk groups, with predicted poor prognosis rates of 11%, 52%, and 87%, respectively.
- The model demonstrated strong predictive accuracy with an area under the curve (AUC) of 0.844 in the derivation cohort and 0.831 in the validation cohort.
Conclusions:
- The newly developed scoring model offers improved prognostication for patients with poor-grade aSAH.
- This tool can assist clinicians in making informed decisions regarding further management and complementary treatments for aSAH patients.

